[1]
“Evaluation of Pioglitazone Vildagliptin Combination on Lipid Profiles for Outpatients with Type II Diabetes Mellitus ”, JFM, vol. 7, no. 2, pp. 398–406, Apr. 2025, doi: 10.35451/jfm.v7i2.2645.